18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients

The diagnostic value of 11C-methionine PET in hyperparathyroidism with negative 99mTc-MIBI SPECT: a meta-analysis

(2016) Leilei Yuan et al.   ACTA RADIOLOGICA

Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?

(2016) Theresia Weber et al.   WORLD JOURNAL OF SURGERY

The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism

(2016) Scott M. Wilhelm et al.   JAMA Surgery

Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT–CT, ultrasound and first results of 18F-fluorocholine PET–CT

(2015) Wouter P. Kluijfhout et al.   EUROPEAN JOURNAL OF RADIOLOGY

Detection rate of 99m Tc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis

(2015) Giorgio Treglia et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT

(2015) Ka Kit Wong et al.   NUCLEAR MEDICINE COMMUNICATIONS

Localization of Parathyroid Adenoma by 11C-Choline PET/CT

(2014) Marina Orevi et al.   CLINICAL NUCLEAR MEDICINE

18F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study

(2014) Luka Lezaic et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Is18F-Fluorocholine-Positron Emission Tomography/Computerized Tomography a New Imaging Tool for Detecting Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism?

(2014) Laure Michaud et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Parathyroid Scintigraphy

(2012) David Taieb et al.   CLINICAL NUCLEAR MEDICINE